Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of 2018
Legislative Progress
Introduced
February 7, 2018
Latest Action
February 13, 2018
Primary Sponsor
Linda T. SánchezDemocratic(CA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
51pct
6d open
vs 7,393 other HR bills in the 115th — cohort avg 50d
Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of 2018 This bill makes a series of changes to Medicare and the directives of the Center for Medicare and Medicaid Innovation in order to address Alzheimer's disease and related dementias, such as incorporating certain cognitive impairment detection tools and diagnostic service referrals into the Medicare annual wellness visit.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (12)
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2018 · second_quarter · Health Issues
S. 92: Safe and Affordable Drugs from Canada Act S. 201 / H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 2260 / H.R. 4733: Opioids and STOP Pain Initiative Act H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 1876: Good Samaritan Health Professionals Act of 2017 H.R. 2077: the Restoring the Patient's Voice Act of 2017 H.R. 4116: Transparent Drug Pricing Act of 2017 S. 2387 / H.R. 4957: Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act S. 2406: Advancing Cutting Edge (ACE) Research Act S. 2478: End Taxpayer Subsidies for Drug Ads Act S. 2680: Opioid Crisis Response Act of 2018 S. 2891: Fighting the Opioid Epidemic with Sunshine Act H.R. 5634: Medical Cannabis Research Act Maintenance/expansion of Graduate Medical Education (GME); encouraging drug price transparency; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues.
Client expense: $220,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
P.L. 111-375 National Alzheimer's Project Act, All Sections P.L. 115-119 Recognize, Assist, Include, Support and Engage (RAISE) Family Caregivers Act S.311/H.R.2972 Alzheimer's Caregiver Support Act H.R. 1676/S. 693 The Palliative Care and Hospice Education and Training Act S. Res 49 A resolution declaring that achieving the primary goal of the National Plan to Address Alzheimer's Disease of the Department of Health and Human Services to prevent and effectively treat Alzheimer's disease by 2025 is an urgent national priority H.R.2953/S.2164 Preventive Health Savings Act S. 464 the Independence at Home Act of 2017 S. 547 Senior Financial Empowerment Act of 2017 S. 1606 In-Home CARE Act H.R.2505/S.1151 Credit for Caring Act H.R.2797/S.1334 Patient Choice and Quality Care Act H.R.2973/S.2208 Alzheimer's Disease Semipostal Stamp Act S.2076/H.R.4256 BOLD Infrastructure for Alzheimer's Act S.1188/H.R.2535 Lifespan Respite Care Reauthorization Act H.R.5191 Medical Improvement of Neurodegenerative Diseases (MIND) Act of 2018 S.2387/H.R.4957 Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of 2018 H.R.3493/S.3608 Care Corps Demonstration Act The CY 2018 Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Medicare Part B H.R.6561 Comprehensive Care for Seniors Act of 2018 H.R.6646 Younger-Onset Alzheimer's Disease Parity Act H.R.6502 Reducing Unnecessary Senior Hospitalizations (RUSH) Act of 2018 S.3412 Paid Family Leave Pilot Act
Client expense: $480,000 · Firm income: Not reported
2018 · fourth_quarter · Health Issues
General education about improving research and public health programs to address Alzheimer's. Concentrating on high-value Alzheimer's Needs to End Act, H.R. 4957, S. 2387.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2018 · fourth_quarter · Medicare/Medicaid
General education about improving research and public health programs to address Alzheimer's. Concentrating on high-value Alzheimer's Needs to End Act, H.R. 4957, S. 2387.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
2018 · fourth_quarter · Medical/Disease Research/Clinical Labs
General education about improving research and public health programs to address Alzheimer's. Concentrating on high-value Alzheimer's Needs to End Act, H.R. 4957, S. 2387.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
| Republican |
| FL |
| Brian Higgins | Democratic | NY |
| Brian J. Mast | Republican | FL |
| Brian K. Fitzpatrick | Republican | PA |
| Christopher H. Smith | Republican | NJ |
| Earl Blumenauer | Democratic | OR |
| Erik Paulsen | Republican | MN |
| Gus M. Bilirakis | Republican | FL |
| Henry C. "Hank" Johnson, Jr. | Democratic | GA |
| Jamie Raskin | Democratic | MD |
| Lucille Roybal-Allard | Democratic | CA |
| Mark Pocan | Democratic | WI |
| Maxine Waters | Democratic | CA |
| Michelle Lujan Grisham | Democratic | NM |
| Paul Tonko | Democratic | NY |
| Peter A. DeFazio | Democratic | OR |
| Peter J. Roskam | Republican | IL |
| Ted Lieu | Democratic | CA |
| Thomas J. Rooney | Republican | FL |
| Tom Cole | Republican | OK |
| Zoe Lofgren | Democratic | CA |
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2018 · fourth_quarter · Health Issues
Step Therapy Reform HR 2077 Labor HHS Appropriations - Alzheimer's Research & 21st Century Cures implementation, BOLD Act (S. 2076, H.R. 4256),CHANGE Act (S. 2387, H.R. 4957), Excellence in Mental Health Care Act (H.R. 3931, S. 1905), HDHP & HSA bills (HR 4978, S. 2410), Medicare Part D, 6 protected classes
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
S. 2387, H.R. 4957: Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2018 · fourth_quarter · Medicare/Medicaid
S. 977/HR 3820 and HR 6225: Medicare Home Health Flexibility Act - Advocate for passage . HR 2550: Medicare Telehealth Parity Act of 2017 - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare. HR2556: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; S787: A bill to require the Center for Medicare and Medicaid Innovation to test the effect of including telehealth services in Medicare health care delivery reform models; HR3360: Telehealth Enhancement Act; HR3482: Evidence-Based Telehealth Expansion Act; S1016: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act; and HR3727: A bill to amend title XVIII of the Social Security Act to include additional telehealth services for purposes of MA organization bids, and for other purposes. - Advocated for the inclusion of occupational therapy as part of telehealth legislation that would allow for reimbursement of certain telehealth services under Medicare. No bill# Red Tape Reduction Initiative from Ways and Means Committee: Submitted following priorities for occupational therapy red tape reduction - 1) Initiation of Home Health Therapy Services Under Medicare (S. 977/HR 3820 now HR 6225), 2) Recognition of Occupational Therapy as a Primary Rehab Service (no bill number), 3) Permanently Eliminate Outside Certification Requirement for Occupational Therapists to Fabricate Custom Orthotics and Prosthetic Items (no bill number), 4) Modify or Eliminate Claims-Based Data Collection of Functional Limitation Information for Therapy Services (no bill number), 5) Add Doctor-prescribed Compression Supplies to the Durable Medical Equipment category (S 497/HR 930), and 6) Medicare Opt-out Option (no bill number). No Bill: Discussed how Stark laws affect the ability of occupational therapy practitioners to provide coordinated care services, particularly as it relates to the management of chronic conditions. S. 497/HR 930: Lymphedema Treatment Act - Support passage. No bill: Advocate for role of skilled therapy in changing reimbursement under Medicare Part A and Part B. HR 6 SUPPORT for Patients and Communities Act (PL 115-271) and various bills on opioids HR 5722, HR 5774, HR 5776, HR 6110, S 3008 and S 3120: Educate Members of Congress about the role of occupational therapy in the non-pharmacological management of pain, and advocate for any legislation that includes studies or funding for these alternatives, includes occupational therapy. Discussed and examined the effect of changes to reimbursement for occupational therapy assistants included in the Bi-partisan Budget Act, and possibly requesting a report from the GAO. S. 2387/HR 4957 - Concentrating on High-value Alzheimer's Needs to Get to an End (CHANGE) Act of 2018: Support
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
No bill #: Educated about the role of occupational therapy in falls prevention. HR 1757 Trauma Informed Care for Children and Families: Educated about occupational therapy's role. HR 6 SUPPORT for Patients and Communities Act (PL 115-271) and various bills on opioids HR 5722, HR 5774, HR 5776, HR 6110, S 3008 and S 3120: Educate Members of Congress about the role of occupational therapy in the non-pharmacological management of pain, and advocate for any legislation that includes studies or funding for these alternatives, includes occupational therapy. No bill: Educate members of occupational therapy's role in general mental health care and trauma informed care. S. 2152 - The Amy, Vicky and Andy Child Pornography Victim Assistance Act of 2018: Support especially including services for occupational therapy as covered. HR 6615/S. 3657 - The Traumatic Brain Injury Program Reauthorization Act of 2018 (PL 15-377): Support No bill#: Support for expanding and extending the Excellence in Mental Health Act. S. 3796/HR 6897 - Mental Health Professionals Workforce Shortage Loan Repayment Act of 2018: Advocate for inclusion of occupational therapy and educate about role of occupational therapy. S. 2076/HR 4256 - Bold Infrastructure for Alzheimer's Act (PL 115-406) - Support S. 2387/HR 4957 - Concentrating on High-value Alzheimer's Needs to Get to an End (CHANGE) Act of 2018: Support
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
General Medicare Protection, Prevention of Fraud, Waste, and Abuse: H.R. 2460 and H.R. 4841 and H.R. 4704, Prescription Drug Re-Importation: S. 92 and S. 469 and H.R. 1245, Negotiation of Prescription Drug Prices: H.R. 242 and S. 41, General Prescription Drug Affordability: S. 124 and S. 771 and H.R. 1776 and H.R. 4138 and H.R. 4116 and H.R. 4117 and S. 2011 and S. 974 and H.R. 2212 and S. 2553, Medicare Enrollment Simplification: H.R. 2575 and S. 1909, Expanding Medicare Coverage: H.R. 5083 and H.R. 4957 and S. 2387 and H.R. 807 and H.R. 3098 and H.R. 4701 and H.R. 508 and H.R. 2276 and S. 2575 and H.R. 5083.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
HR4957 / S2387 Change Act. Concentrating on High Value Alzheimers Needs to get to an End
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Medicare/Medicaid
S. 445 - the Home Health Care Planning Improvement Act of 2017 S. 464 - Independence at Home Act of 2017 H.R. 1825, the Home Care Planning Act S. 2387/H.R. 4957 - The Concentrating on High-Value Alzheimer's Needs to Get to and End (CHANGE) Act
Client expense: $39,500 · Firm income: Not reported
Government targets: Administration on Aging, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2018 · fourth_quarter · Health Issues
S. 464 - Independence at Home Act of 2017 S. 693/H.R. 1676 - Palliative Care and Hospice Education and Training Act (PCHETA) S. 1334/H.R. 2797 - Patient Choice and Quality Care of Act of 2017 (PCQCA) S. 2076/H.R. 4256 - the BOLD Infrastructure for Alzheimer's Act S. 2387/H.R. 4957 - The Concentrating on High-Value Alzheimer's Needs to Get to and End (CHANGE) Act
Client expense: $39,500 · Firm income: Not reported
Government targets: Administration on Aging, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2018 · fourth_quarter · Health Issues
S. 2387/H.R. 4957: Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act --legislation to provide better care and outcomes for Americans living with Alzheimer's disease and their caregivers while improving prevention strategies and disease modifying treatments.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · fourth_quarter · Health Issues
General education about improving research and public health programs to address Alzheimer's. Concentrating on High-Value Alzheimer's Needs to End Act, H.R. 4957, S. 2387
Client expense: Not reported · Firm income: Not reported
2018 · fourth_quarter · Medicare/Medicaid
General education about improving research and public health programs to address Alzheimer's. Concentrating on High-Value Alzheimer's Needs to End Act, H.R. 4957, S. 2387
Client expense: Not reported · Firm income: Not reported
2018 · fourth_quarter · Medical/Disease Research/Clinical Labs
General education about improving research and public health programs to address Alzheimer's. Concentrating on High-Value Alzheimer's Needs to End Act, H.R. 4957, S. 2387
Client expense: Not reported · Firm income: Not reported
2018 · third_quarter · Health Issues
P.L. 111-375 National Alzheimer's Project Act, All Sections S.311/H.R.2972 Alzheimer's Caregiver Support Act H.R. 1676/S. 693 The Palliative Care and Hospice Education and Training Act S. Res 49 A resolution declaring that achieving the primary goal of the National Plan to Address Alzheimer's Disease of the Department of Health and Human Services to prevent and effectively treat Alzheimer's disease by 2025 is an urgent national priority H.R.2953/S.2164 Preventive Health Savings Act S. 464 the Independence at Home Act of 2017 S. 547 Senior Financial Empowerment Act of 2017 S. 1606 In-Home CARE Act H.R.2505/S.1151 Credit for Caring Act H.R.2797/S.1334 Patient Choice and Quality Care Act H.R.2973/S.2208 Alzheimer's Disease Semipostal Stamp Act S.2076/H.R.4256 BOLD Infrastructure for Alzheimer's Act S.1188/H.R.2535 Lifespan Respite Care Reauthorization Act H.R.5191 Medical Improvement of Neurodegenerative Diseases (MIND) Act of 2018 S.2387/H.R.4957 Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of 2018 H.R.3493 Care Corps Demonstration Act The CY 2018 Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Medicare Part B H.R.6561 Comprehensive Care for Seniors Act of 2018 H.R.6646 Younger-Onset Alzheimer's Disease Parity Act H.R.6502 Reducing Unnecessary Senior Hospitalizations (RUSH) Act of 2018
Client expense: $480,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Justice, Dept of (DOJ), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2018 · third_quarter · Health Issues
HR 4957 / S 2387 " The Change Act" Concentrating on High Value Alzheimers Needs to Get to and End
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
HR4957 / S2387 Change Act. Concentrating on High Value Alzheimers Needs to get to an End
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
S. 2387, H.R. 4957: Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2018 · third_quarter · Health Issues
Step Therapy Reform HR 2077 Labor HHS Appropriations - Alzheimer's Research & 21st Century Cures implementation, BOLD Act (S. 2076, H.R. 4256),CHANGE Act (S. 2387, H.R. 4957), Excellence in Mental Health Care Act (H.R. 3931, S. 1905), HDHP & HSA bills (HR 4978, S. 2410), Medicare Part D, 6 protected classes
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Medicare/Medicaid
S. 445 - the Home Health Care Planning Improvement Act of 2017 S. 464 - Independence at Home Act of 2017 H.R. 1825, the Home Care Planning Act S. 2387/H.R. 4957 - The Concentrating on High-Value Alzheimer's Needs to Get to and End (CHANGE) Act
Client expense: $37,000 · Firm income: Not reported
Government targets: Administration on Aging, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2018 · third_quarter · Health Issues
S. 464 - Independence at Home Act of 2017 S. 693/H.R. 1676 - Palliative Care and Hospice Education and Training Act (PCHETA) S. 1334/H.R. 2797 - Patient Choice and Quality Care of Act of 2017 (PCQCA) S. 2076/H.R. 4256 - the BOLD Infrastructure for Alzheimer's Act S. 2387/H.R. 4957 - The Concentrating on High-Value Alzheimer's Needs to Get to and End (CHANGE) Act
Client expense: $37,000 · Firm income: Not reported
Government targets: Administration on Aging, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2018 · third_quarter · Medicare/Medicaid
Hearing Health Care Services. S. 2575/H.R. 2276, Audiology Patient Choice Act of 2018: Proposal to expand access to hearing health care services for Medicare beneficiaries. Hearing Aids. H.R. 3426, Medicare Hearing Aid Coverage Act: Proposal to provide Medicare coverage of hearing aids. Medicare Dental, Vision, and Hearing Coverage. H.R. 508, Seniors Have Eyes, Ears and Teeth Act and H.R. 3111, Medicare Dental, Vision, and Hearing Benefit Act of 2017: Proposals to expand Medicare coverage to include comprehensive coverage of dental, vision, and hearing care. Medicare Observation Status. S. 568/H.R. 1421, Improving Access to Medicare Coverage Act of 2017: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Dementia and Alzheimers. S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act): Proposal to apply a public health approach to combat Alzheimers disease and related dementias. Alzheimers Disease. S. 2387/H.R. 4957, Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act of 2018: Proposal to aid Alzheimers disease suffers, their families and caregivers, including authorization of a cognitive impairment detection benefit in the Medicare annual wellness visit and initial preventive physical examination. Drug Price Negotiation. S. 2011/H.R. 4138, Medicare Drug Price Negotiation Act: Proposals to lower prescription drug prices in the Medicare Part D program, including allowing Medicare to negotiate directly with prescription drug manufacturers and requiring drug manufacturers to rebate to the federal government for drugs covered under Medicare Part D for low-income Medicare beneficiaries. Generic Drug Introduction. S. 974/H.R. 2212, CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval. Opioid Treatment. H.R. 6, SUPPORT for Patients and Communities Act: Section 2005 proposals related to Medicare coverage of certain services furnished by opioid treatment programs. Medicare Beneficiary Equitable Relief. (No bill): Efforts to extend and make permanent the Centers for Medicare and Medicaid Services policy for equitable relief for select individuals currently or previously enrolled in Marketplace plans who delayed Medicare enrollment during their Initial Enrollment Period or during a qualifying Special Enrollment Period. Medicare Physician Payment. (No bill): Proposal to collapse the current five levels of payments for office visits (Evaluation and Management) into two levels. Medicare and Medicaid Protection. S. 3330, Medicare and Medicaid Protection Act: Proposed changes to budget reconciliation legislation affecting Medicare and Medicaid program protections. Medicaid Protection. (No bill): Proposals requiring Medicaid recipients to work and ending homecare workers rights to make deductions from their pay for health care and union dues. Medicare Prescription Drug Costs. (May be attached to several legislative vehicles.) Proposals to reduce amount drug manufacturers must contribute to closing the donut hole. Medicare Prescription Drug Costs. S. 2553, Know the Lowest Price Act of 2018: Proposal to prohibit Medicare Advantage plans from putting clauses in contracts with pharmacists prohibiting them from disclosing to beneficiaries when a drug is less expensive if the beneficiary doesnt use his or her insurance. Medicare Part B Drug Costs. H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018: Proposal to reduce Medicare Part B drug costs by requiring Medicare to rebate to the government the amount by which a drug price increase exceeds an inflation limit. Medicare Open Enrollment. (No bill). Efforts to ensure the Centers for Medicare and Medicaid Services conducts open enrollment in a way that is unbiased toward the traditional program.
Client expense: $210,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), SENATE, Social Security Administration (SSA), Treasury, Dept of
2018 · third_quarter · Medicare/Medicaid
General Medicare Protection, Prevention of Fraud, Waste, and Abuse: H.R. 2460 and H.R. 4841 and H.R. 4704, Prescription Drug Re-Importation: S. 92 and S. 469 and H.R. 1245, Negotiation of Prescription Drug Prices: H.R. 242 and S. 41, General Prescription Drug Affordability: S. 124 and S. 771 and H.R. 1776 and H.R. 4138 and H.R. 4116 and H.R. 4117 and S. 2011 and S. 974 and H.R. 2212 and S. 2553, Medicare Enrollment Simplification: H.R. 2575 and S. 1909, Expanding Medicare Coverage: H.R. 5083 and H.R. 4957 and S. 2387 and H.R. 807 and H.R. 3098 and H.R. 4701 and H.R. 508 and H.R. 2276 and S. 2575 and H.R. 5083.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · third_quarter · Health Issues
S. 2387/H.R. 4957: Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act --legislation to provide better care and outcomes for Americans living with Alzheimer's disease and their caregivers while improving prevention strategies and disease modifying treatments.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
P.L. 111-375 National Alzheimer's Project Act, All Sections S.311/H.R.2972 Alzheimer's Caregiver Support Act H.R. 1676/S. 693 The Palliative Care and Hospice Education and Training Act S. Res 49 A resolution declaring that achieving the primary goal of the National Plan to Address Alzheimer's Disease of the Department of Health and Human Services to prevent and effectively treat Alzheimer's disease by 2025 is an urgent national priority H.R.2953/S.2164 Preventive Health Savings Act S. 464 the Independence at Home Act of 2017 S. 547 Senior Financial Empowerment Act of 2017 S. 1606 In-Home CARE Act H.R.2505/S.1151 Credit for Caring Act H.R.2797/S.1334 Patient Choice and Quality Care Act H.R.2973/S.2208 Alzheimer's Disease Semipostal Stamp Act S.2076/H.R.4256 BOLD Infrastructure for Alzheimer's Act S.1188/H.R.2535 Lifespan Respite Care Reauthorization Act H.R.5191 Medical Improvement of Neurodegenerative Diseases (MIND) Act of 2018 S.2387/H.R.4957 Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of 2018 H.R.3493 Care Corps Demonstration Act
Client expense: $400,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2018 · second_quarter · Health Issues
Step Therapy Reform HR 2077 Labor HHS Appropriations - Alzheimer's Research & 21st Century Cures implementation, BOLD Act (S. 2076, H.R. 4256),CHANGE Act (S. 2387, H.R. 4957), Excellence in Mental Health Care Act (H.R. 3931, S. 1905), HDHP & HSA bills (HR 4978, S. 2410), Medicare Part D, 6 protected classes
Client expense: $300,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
S. 92: Safe and Affordable Drugs from Canada Act S. 201 / H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 S. 469: Affordable and Safe Prescription Drug Importation Act S. 1131/ H.R. 2439: FAIR Drug Pricing Act S. 2260 / H.R. 4733: Opioids and STOP Pain Initiative Act H.R. 1776: Improving Access to Affordable Prescription Drugs Act H.R. 1876: Good Samaritan Health Professionals Act of 2017 H.R. 2077: the Restoring the Patient's Voice Act of 2017 H.R. 4116: Transparent Drug Pricing Act of 2017 S. 2387 / H.R. 4957: Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act S. 2406: Advancing Cutting Edge (ACE) Research Act S. 2478: End Taxpayer Subsidies for Drug Ads Act S. 2680: Opioid Crisis Response Act of 2018 S. 2891: Fighting the Opioid Epidemic with Sunshine Act H.R. 5634: Medical Cannabis Research Act Maintenance/expansion of Graduate Medical Education (GME); encouraging drug price transparency; NIH funding including the BRAIN Initiative; Congressionally-Directed Medical Research Program funding; concussion related issues.
Client expense: Not reported · Firm income: $220,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
PL 111-375 - The National Alzheimer's Project Act, implementation Health Outcomes, Planning and Education for Alzheimer's, implementation PL 114-255 - 21st Century Cures, implementation H.R 1628 - American Health Care Act of 2017 H.R. 1676/S. 693 - Palliative Care and Hospice Education and Training Act S. Res. 49 - Alzheimer's as Urgent National Priority H.R. 3263/S. 464 - Independence at Home Act S. 870 - Chronic Care H.R. 2430 - FDA Reauthorization Act of 2017 S. 1827- KIDS Act of 2017 H.R. 4256/S. 2076 - BOLD Act of 2017 H.R. 4957 - CHANGE Act of 2018 no specific bill, Older Americans' Act Reauthorization, care planning, home and community based care, Independence at Home, CDC Centers of Excellence
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2018 · second_quarter · Medicare/Medicaid
Hearing Health Care Services. S. 2575/H.R. 2276, Audiology Patient Choice Act of 2018: Proposal to expand access to hearing health care services for Medicare beneficiaries. Hearing Aids. H.R. 3426, Medicare Hearing Aid Coverage Act: Proposal to provide Medicare coverage of hearing aids. Medicare Dental, Vision, and Hearing Coverage. H.R. 508, Seniors Have Eyes, Ears and Teeth Act and H.R. 3111, Medicare Dental, Vision, and Hearing Benefit Act of 2017: Proposals to expand Medicare coverage to include comprehensive coverage of dental, vision, and hearing care. Medicare Observation Status. S. 568/H.R. 1421, Improving Access to Medicare Coverage Act of 2017: Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility. Opioid Treatment. S. 2704/H.R. 4097, Medicare Beneficiary Opioid Addiction Treatment Act: Proposal to provide for coverage of methadone under Medicare Part B. Dementia and Alzheimers. S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act): Proposal to apply a public health approach to combat Alzheimers disease and related dementias; Alzheimers Disease. S. 2387/H.R. 4957, Concentrating on High-Value Alzheimers Needs to Get to an End (CHANGE) Act of 2018: Proposal to aid Alzheimers disease suffers, their families and caregivers, including authorization of a cognitive impairment detection benefit in the Medicare annual wellness visit and initial preventive physical examination. Drug Price Negotiation. S. 2011/H.R. 4138, Medicare Drug Price Negotiation Act: Proposals to lower prescription drug prices in the Medicare Part D program, including allowing Medicare to negotiate directly with prescription drug manufacturers and requiring drug manufacturers to rebate to the federal government for drugs covered under Medicare Part D for low-income Medicare beneficiaries. Generic Drug Introduction. S. 974/H.R. 2212, CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval. Prescription Drug costs. S. 2553/H.R. 6144, the Know the Lowest Price Act: Proposal to prohibit health plans and pharmacy benefits managers from utilizing contract gag clauses prohibiting pharmacists from disclosing to consumers when it costs less to pay out-of-pocket for a prescription than it would using their insurance coverage. Medicare Part B Drug Costs . H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018: Proposal to reduce Medicare Part B drug costs by requiring Medicare to rebate to the government the amount by which a drug price increase exceeds an inflation limit. Medicare Beneficiary Education. (No bill): Efforts to improve the Centers for Medicare and Medicaid outreach and education during open enrollment.
Client expense: $260,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Office of Management & Budget (OMB), President of the U.S., SENATE, Social Security Administration (SSA), Treasury, Dept of, Vice President of the U.S.
2018 · second_quarter · Medicare/Medicaid
General Medicare Protection, Prevention of Fraud, Waste, and Abuse: H.R. 2460 and H.R. 4841 and H.R. 4704, Prescription Drug Re-Importation: S. 92 and S. 469 and H.R. 1245, Negotiation of Prescription Drug Prices: H.R. 242 and S. 41, General Prescription Drug Affordability: S. 124 and S. 771 and H.R. 1776 and H.R. 4138 and H.R. 4116 and H.R. 4117 and S. 2011 and S. 974 and H.R. 2212 and S. 2553, Medicare Enrollment Simplification: H.R. 2575 and S. 1909, Expanding Medicare Coverage: H.R. 5083 and H.R. 4957 and S. 2387 and H.R. 807 and H.R. 3098 and H.R. 4701 and H.R. 508 and H.R. 2276 and S. 2575 and H.R. 5083.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Health Issues
S. 2387/H.R. 4957: Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act --legislation to provide better care and outcomes for Americans living with Alzheimer's disease and their caregivers while improving prevention strategies and disease modifying treatments.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · second_quarter · Medicare/Medicaid
S. 445 - the Home Health Care Planning Improvement Act of 2017 S. 464 - Independence at Home Act of 2017 H.R. 1825, the Home Care Planning Act S. 2387/H.R. 4957 - The Concentrating on High-Value Alzheimer's Needs to Get to and End (CHANGE) Act
Client expense: $36,000 · Firm income: Not reported
Government targets: Administration on Aging, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2018 · first_quarter · Health Issues
P.L. 111-375 National Alzheimer's Project Act, All Sections S.311/H.R.2972 Alzheimer's Caregiver Support Act H.R. 1676/S. 693 The Palliative Care and Hospice Education and Training Act S. Res 49 A resolution declaring that achieving the primary goal of the National Plan to Address Alzheimer's Disease of the Department of Health and Human Services to prevent and effectively treat Alzheimer's disease by 2025 is an urgent national priority S. 464 the Independence at Home Act of 2016 S. 547 Senior Financial Empowerment Act of 2017 S. 1606 In-Home CARE Act H.R.2953/S.2164 Preventive Health Savings Act H.R.2505/S.1151 Credit for Caring Act H.R.2797/S.1334 Patient Choice and Quality Care Act H.R.2973/S.2208 Alzheimer's Disease Semipostal Stamp Act H.R.3263 To amend title XVIII of the Social Security Act to extend the Medicare independence at home medical practice demonstration program S.870/H.R.4579 CHRONIC Care Act S.2070/H.R.4221 Kevin and Avonte's Law of 2017 S.2076/H.R.4256 BOLD Infrastructure for Alzheimer's Act S.1188/H.R.2535 Lifespan Respite Care Reauthorization Act H.R.5191 Medical Improvement of Neurodegenerative Diseases (MIND) Act of 2018 S.2387/H.R.4957 Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act of 2018
Client expense: $316,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, Interior, Dept of (DOI), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
2018 · first_quarter · Health Issues
PL 111-375 - The National Alzheimer's Project Act, implementation Health Outcomes, Planning and Education for Alzheimer's, implementation PL 114-255 - 21st Century Cures, implementation H.R 1628 - American Health Care Act of 2017 H.R. 1676/S. 693 - Palliative Care and Hospice Education and Training Act S. Res. 49 - Alzheimer's as Urgent National Priority H.R. 3263/S. 464 - Independence at Home Act S. 870 - Chronic Care H.R. 2430 - FDA Reauthorization Act of 2017 S. 1827- KIDS Act of 2017 H.R. 4256/S. 2076 - BOLD Act of 2017 H.R. 4957 - CHANGE Act of 2018 no specific bill, Older Americans' Act Reauthorization, care planning, home and community based care, Independence at Home, CDC Centers of Excellence
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2018 · first_quarter · Health Issues
S2387 and HR4957 The CHANGE Act.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Medicare/Medicaid
General Medicare Protection, Prevention of Fraud, Waste, and Abuse: H.R. 2460 and H.R. 4841 and H.R. 4704, Prescription Drug Re-Importation: S. 92 and S. 469 and H.R. 1245, Negotiation of Prescription Drug Prices: H.R. 242 and S. 41, General Prescription Drug Affordability: S. 124 and S. 771 and H.R. 1776 and H.R. 4138 and H.R. 4116 and H.R. 4117 and S. 2011 and S. 974 and H.R. 2212, Medicare Enrollment Simplification: H.R. 2575 and S. 1909, Expanding Medicare Coverage: H.R. 5083 and H.R. 4957 and S. 2387 and H.R. 807 and H.R. 3098 and H.R. 4701.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2018 · first_quarter · Health Issues
S. 2387/H.R. 4957: Concentrating on High-Value Alzheimer's Needs to Get to an End (CHANGE) Act --legislation to provide better care and outcomes for Americans living with Alzheimer's disease and their caregivers while improving prevention strategies and disease modifying treatments.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE